Clinical Trials on Consumer Willingness to Pay for POU Products in Canada
Total 0 results
Nothing found
Sponsors and Collaborators
- EXCELYA Bordeaux
- EndoTheia
- kıvan çevik kaya
- Diabetes Research Institute, Munich, Germany.
- South Texas Health System McAllen
- Orthopädisch-Unfallchirurgische Praxis Dr Lembeck & Dr Pampel
- Critical Care Pharmacotherapy Trials Network
- Phoenix VA Health Care System
- Rivus Pharmaceuticals, Inc.
- Department of Orthopedics, Norrköping
- Canadian Glycomics Network (GlycoNet)
- Merve Şeker
- Retina Foundation of Canada
- Hospital Santos Reyes de Aranda de Duero, Burgos
- Clinic of the International Institute of Postgraduate Education Ministry of Healthcare of the Republic of Kazakhstan
- Pearl Network
- Dr. Khaled Ahmed Yassen
- Bettina Eiger
- Jinxiang County People's Hospital
- Alcohol Education and rehabilitation Fund
- View Full List
Medical Conditions
- Cystic Renal Disease
- Racial Bias
- Encephalitis, Arbovirus
- Acute Rotator Cuff Tear Related to Trauma
- Presence / Absence of EBV
- Newborn Infants
- Poststroke Fatigue
- Myocardial Infarction (MI) or Acute Myocardial Infarction (AMI)
- Ruptured Achilles Tendon
- Secondary Pulmonary Arterial Hypertension
- Dystonic Disorders
- Tumor Cell, Circulating
- Organic Anion Transporting Polypeptide1B1 (OATP1B1)
- 1- Primary (Sarcomeric) Hypertrophic Cardiomyopathy
- Deep Neck Space Infections
- Morton's Neuroma
- Acute Upper Gastrointestinal Non Variceal Hemorrhage
- Myocardial Haemorrhage
- Malignant Pelvic Neoplasm
- Fluorescein Angiography
- View Full List
Drug Interventions
- Granulocyte colony-stimulating factor
- Anastrozole
- Ketamine 0.3 mg/kg at anesthesia induction
- Amisulpride Oral Tablet
- 6-Mercaptopurine
- Vinorelbine tartrate
- Visanne (Dienogest, BAY86-5258)
- Modified Bolus 5-FU/LV with Irinotecan
- Nicoderm C-Q Transdermal Product
- 30 mg CVL-231 as slow-release MR formulation
- Sodium Nitroprusside
- PCO371
- Sipuleucel-T
- Tranexamic acid
- Cetuximab
- Tenofovir
- Trastuzumab in combination with SubQ GM-CSF
- Percutaneous sirolimus
- 5.0g SRT501
- Follitropin beta liquid formulation
- View Full List
CROs by country
- Contract Research Organizations in Colombia
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mexico
- Contract Research Organizations in Panama
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in South Korea
- Contract Research Organizations in Suriname
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Tanzania
- Contract Research Organizations in Ukraine
- CRO list by country